Recovery and recurrence following treatment for adolescent major depression (Q34780705)

4 August 2017

title

Recovery and recurrence following treatment for adolescent major depression (English)

1 reference

4 August 2017

1 reference

11

Norah Feeny

1 reference

4 August 2017

10

Taryn Mayes

1 reference

4 August 2017

18

Graham Emslie

1 reference

4 August 2017

9

Betsy Kennard

1 reference

4 August 2017

21

Barbara Burns

1 reference

4 August 2017

John Curry

1

1 reference

4 August 2017

Susan Silva

2

1 reference

4 August 2017

Paul Rohde

3

1 reference

4 August 2017

Golda Ginsburg

4

1 reference

4 August 2017

Christopher Kratochvil

5

1 reference

4 August 2017

Anne Simons

6

1 reference

4 August 2017

Jerry Kirchner

7

1 reference

4 August 2017

Diane May

8

1 reference

4 August 2017

Anne Marie Albano

12

1 reference

4 August 2017

Sarah Lavanier

13

1 reference

4 August 2017

Mark Reinecke

14

1 reference

4 August 2017

Rachel Jacobs

15

1 reference

4 August 2017

Emily Becker-Weidman

16

1 reference

4 August 2017

Elizabeth Weller

17

1 reference

4 August 2017

John Walkup

19

1 reference

4 August 2017

Elizabeth Kastelic

20

1 reference

4 August 2017

Karen Wells

22

1 reference

4 August 2017

John March

23

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

4 August 2017

1 reference

4 August 2017

volume

68

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

263-269

1 reference

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Is there an epidemic of child or adolescent depression?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Presentation and course of major depressive disorder during childhood and later years of the life span

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Major depression in community adolescents: age at onset, episode duration, and time to recurrence.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

A children's global assessment scale (CGAS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Negative cognitive errors in children: questionnaire development, normative data, and comparisons between children with and without self-reported symptoms of depression, low self-esteem, and evaluation anxiety

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Follow-up and family study of anxious depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Course and outcome of major depressive disorder in non-referred adolescents.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Psychosocial functioning in youths at high risk to develop major depressive disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Emergence of gender differences in depression during adolescence: national panel results from three countries.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Explaining the gender difference in depressive symptoms

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Natural course of adolescent major depressive disorder: I. Continuity into young adulthood

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Psychopathology associated with suicidal ideation and attempts among children and adolescents.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Fluoxetine in child and adolescent depression: acute and maintenance treatment.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074362

Course of major depression in non-referred adolescents: a retrospective study

26 October 2018

1 reference

12 December 2020

Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders

1 reference

12 December 2020

Recurrence of Major Depressive Disorder in Hospitalized Children and Adolescents

1 reference

12 December 2020

Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions

1 reference

12 December 2020

Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder

1 reference

12 December 2020

10.1001/ARCHGENPSYCHIATRY.2010.150

Identifiers

DOI

1 reference

4 August 2017

1 reference

4 August 2017

1 reference